These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6523433)

  • 41. Arterial thrombin activity after angioplasty in an atherosclerotic rabbit model: time course and effect of hirudin.
    Barry WL; Gimple LW; Humphries JE; Powers ER; McCoy KW; Sanders JM; Owens GK; Sarembock IJ
    Circulation; 1996 Jul; 94(1):88-93. PubMed ID: 8964123
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endotoxin-induced changes in the hemostatic system in neonatal calves: the effect of antiserum to a mutant Escherichia coli (J-5).
    Morris DD; Whitlock RH; Merryman GS; Bruce J; Corbeil LB
    Am J Vet Res; 1986 Dec; 47(12):2514-9. PubMed ID: 3541702
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics of 125I-hirudin in rats and dogs.
    Richter M; Cyranka U; Nowak G; Walsmann P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):64-9. PubMed ID: 2459034
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of recombinant hirudin in healthy horses.
    Feige K; Dennler M; Kästner SB; Wunderli-Allenspach H; Demuth D; Huber A
    Equine Vet J; 2004 Mar; 36(2):135-41. PubMed ID: 15038436
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A recombinant hirudin (IK-HIR02) in healthy volunteers. II. Effects on platelet adhesion and platelet-induced thrombin generation time.
    Schenk JF; Glusa E; Radziwon P; Butti A; Markwardt F; Breddin HK
    Haemostasis; 1996; 26(4):187-94. PubMed ID: 8872129
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of basic proteins on the haemostatic system of the dog.
    Worowski K; Głowiński S; Skrzydlewski Z
    Haematologia (Budap); 1978-1979; 12(1-4):165-8. PubMed ID: 575340
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacology of r-hirudin in renal impairment.
    Nowak G; Bucha E; Gööck T; Thieler H; Markwardt F
    Thromb Res; 1992 Jun; 66(6):707-15. PubMed ID: 1519229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hirudin as anticoagulant in experimental hemodialysis.
    Markwardt F; Nowak G; Bucha E
    Haemostasis; 1991; 21 Suppl 1():149-55. PubMed ID: 1894190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Haemostyptic effects of batroxobin with regard to hirudin treatment.
    Markwardt F; Kaiser B; Richter M
    Thromb Res; 1992 Dec; 68(6):475-82. PubMed ID: 1341058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of piroxicam coadministration on pharmacodynamic parameters and the plasma concentration/effect relationship of recombinant hirudin (CGP 39393).
    Thürmann P; Harder S; Kirchmaier CM
    Eur J Clin Pharmacol; 1995; 48(3-4):241-6. PubMed ID: 7589048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sustained bleeding after a leech bite in the apparent absence of hirudin.
    Munro R; Hechtel FO; Sawyer RT
    Thromb Haemost; 1989 Jun; 61(3):366-9. PubMed ID: 2799751
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prothrombin conversion intermediate effectively neutralizes toxic levels of hirudin.
    Nowak G; Bucha E
    Thromb Res; 1995 Nov; 80(4):317-25. PubMed ID: 8585044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A fast photometric assay for the determination of hirudin.
    Spannagl M; Bichler H; Lill H; Schramm W
    Haemostasis; 1991; 21 Suppl 1():36-40. PubMed ID: 1716604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Studies on the influence of glucose infusion on parameters of hemostasis].
    Wamhoff D; Weiss D; Senf L
    Z Gesamte Inn Med; 1976 Sep; 31(17):711-5. PubMed ID: 997669
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of somatostatin on haemostasis in dogs.
    Gabryelewicz A; Prokopowicz J; Hnidec O; Wolosowicz N
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(1):125-31. PubMed ID: 6164606
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recombinant hirudin, a new anticoagulant, has no effect on faecal blood loss.
    Meyer BH; Luus HG; Muller FO; Badenhorst PN; Lotter MG; Röthig HJ; Grötsch H; Rosenkranz B
    Br J Clin Pharmacol; 1992 May; 33(5):524-6. PubMed ID: 1524967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies on the pharmacokinetics and pharmacodynamics of recombinant hirudin (rHV2-Lys 47) after intravenous and subcutaneous administration in dogs.
    Iyer L; Koza M; Iqbal O; Calabria R; Fareed J
    Thromb Res; 1993 Feb; 69(3):259-69. PubMed ID: 8475476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radioimmunoassay for the detection of active-site specific thrombin inhibitors in biological fluids. I. Assay characteristics and quantitation of recombinant hirudin.
    Lackmann M; Hoad R; Kakakios A; Geczy CL
    Thromb Res; 1991 Sep; 63(6):595-607. PubMed ID: 1780804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-hirudin antibodies alter pharmacokinetics and pharmacodynamics of recombinant hirudin.
    Fischer KG; Liebe V; Hudek R; Piazolo L; Haase KK; Borggrefe M; Huhle G
    Thromb Haemost; 2003 Jun; 89(6):973-82. PubMed ID: 12783109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oxidative folding of hirudin in human serum.
    Chang JY; Lu BY; Lai PH
    Biochem J; 2006 Feb; 394(Pt 1):249-57. PubMed ID: 16271042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.